ClinVar Miner

Submissions for variant NM_000267.3(NF1):c.4269G>A (p.Lys1423=) (rs199474750)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000485227 SCV000573246 likely pathogenic not provided 2017-02-24 criteria provided, single submitter clinical testing The c.4269 G>A (K1423K) variant has been published previously in association with neurofibromatosis type 1 (Sites et al., 2016). The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). While the variant is a synonymous nucleotide change that does not alter the amino acid sequence, the variant occurs at a nucleotide that is conserved across species. In silico analysis predicts this variant destroys the natural splice donor site of intron 31. Additionally, cell lines containing this variant were able to form colonies and lost contact inhibition; they also showed the ability to form tumors when introduced to mice (Li et al., 2016). In summary, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.
Invitae RCV000497159 SCV000628581 uncertain significance Neurofibromatosis, type 1 2019-05-16 criteria provided, single submitter clinical testing This sequence change affects codon 1423 of the NF1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the NF1 protein. This variant also falls at the last nucleotide of exon 31 of the NF1 coding sequence, which is part of the consensus splice site for this exon. Nucleotide substitutions within the consensus splice site are relatively common causes of aberrant splicing (PMID: 17576681, 9536098). This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with neurofibromatosis type 1 in the literature and in the Leiden Open-source Variation Database (PMID: 27862945, 28068329, 21520333). ClinVar contains an entry for this variant (Variation ID: 423536). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. A different variant affecting this nucleotide (c.4269G>C) has been determined to be pathogenic (PMID: 18546366). This suggests that this nucleotide is important for normal RNA splicing, and that other variants at this position may also be pathogenic. In summary, this variant has uncertain impact on NF1 function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Center for Human Genetics, Inc,Center for Human Genetics, Inc RCV000497159 SCV000782016 likely pathogenic Neurofibromatosis, type 1 2016-11-01 criteria provided, single submitter clinical testing
Medical Genetics, University of Parma RCV000497159 SCV000588779 uncertain significance Neurofibromatosis, type 1 2017-02-02 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.